جست‌وجوی استاد و پژوهشگر

• Hypertension
• Cardiorenal Disease
• Metabolic Disease
• +۳ مورد دیگر

Markus Schlaich is a Professor and holds the Dobney Chair in Clinical Research at the University of Western Australia (UWA) and Royal Perth Hospital. He is affiliated with the UWA Medical School and the Department of Internal Medicine. His expertise lies in hypertension, cardiorenal disease, and metabolic disorders, with a focus on the sympathetic nervous system and renal denervation. He leads the Dobney Hypertension Centre, aiming to develop novel therapies for hypertension and its complications. Education & Career: Relocated from Germany in 2006, previously Head of the 'Neurovascular Hypertension & Kidney Disease Laboratory' at Baker IDI Heart and Diabetes Research Institute. Currently serves on multiple committees, including the Executive Committee of the High Blood Pressure Research Council of Australia and the International Society of Hypertension. Research Interests: Pathophysiology of hypertension, sympathetic nervous system modulation, renal denervation, and clinical translation of therapies. Key contributions include advancing renal denervation as a treatment for resistant hypertension. Awards: Recipient of the Australian Museum Eureka Prize for Medical Research Translation and 18 other research awards. Recognized for work in hypertension and cardiorenal/metabolic disease. Grants & Projects: Leads or co-investigates 33 grants, including NHMRC Senior Research Fellowship. Active in projects like the Primary Aldosteronism Centre of Excellence and studies on SGLT inhibitors' cardiorenal effects. Labs & Teams: Heads the interdisciplinary Dobney Hypertension Centre, focusing on translational research and clinical innovation. Collaborates internationally on studies like the Global Burden of Disease initiative.

• Cancer Biology
• Biochemistry
• Telomere Biology
• +۴ مورد دیگر

Professor Tracy Bryan is a Professor in the Faculty of Medicine and Health at the University of Sydney and serves as Unit Head of the Cell Biology Unit at the Children's Medical Research Institute (CMRI). She holds a Bachelor of Science from Macquarie University and a PhD from the CMRI, where her groundbreaking research identified the ALT (Alternative Lengthening of Telomeres) mechanism in cancer cells. After postdoctoral work with Nobel Laureate Tom Cech at the University of Colorado, she returned to Australia in 2001 to establish her research group at CMRI. Her research focuses on telomerase biology, particularly its role in cancer progression and bone marrow failure syndromes. Key themes include understanding telomerase mechanisms, developing inhibitors for cancer therapy, and investigating telomere biology disorders. Her work integrates biochemical and cell-based approaches, supported by grants from NHMRC, Viertel Foundation, and Cancer Council NSW. Recent publications highlight advancements in telomerase-substrate interactions, i-motif DNA structures, and the interplay between telomere maintenance and DNA damage responses. Major grants include NHMRC Ideas Grants targeting telomere-related bone marrow failure and ARC Discovery Projects exploring DNA replication-telomere links. Bryan’s research group collaborates internationally, contributing to translational studies in oncology and regenerative medicine. Her lab’s work is detailed at CMRI’s Cell Biology Team page, with ongoing projects focused on telomerase inhibition strategies and molecular mechanisms of telomere dysfunction.

Rachel Baileyمشاهده پروفایل

پژوهشگر

• Gene Therapy
• Neurodegenerative Diseases
• Tauopathies
• +۷ مورد دیگر

Rachel Bailey is a researcher at UT Southwestern with a focus on developing gene therapies for neurological disorders. She holds dual bachelor's degrees in Biology/Bioinformatics and Molecular Biology from Rensselaer Polytechnic Institute, a Ph.D. in Neuroscience from the University of Florida, and completed postdoctoral research at the University of North Carolina Chapel Hill. Education : Dual B.S. from Rensselaer Polytechnic Institute, Ph.D. in Neuroscience Her research spans gene therapy for monogenic and complex neurodegenerative diseases, including SLC13A5 epileptic encephalopathy , Giant Axonal Neuropathy , and tauopathies like Alzheimer’s disease. She employs AAV vector engineering for gene replacement and silencing, with expertise in preclinical development and IND-enabling studies . Recent publications highlight her work on tau protein phosphorylation in Parkinson’s disease, AAV9 gene therapy for GAN, and autonomic dysfunction in neurodegenerative models. Key collaboration networks include institutions like the NIH and Mayo Clinic.

Kathryn E. Dickersonمشاهده پروفایل

استادیار

• Pediatric Hematology
• Myeloid Malignancies
• Epigenetic Regulation
• +۴ مورد دیگر

Kathryn E. Dickerson, M.D., M.S.C.S., is an Assistant Professor in the Department of Pediatrics at UT Southwestern Medical Center, specializing in the Division of Hematology and Oncology. She holds dual appointments as a 2015 Translational Research Scholar in the UTSW Center for Translational Medicine and as an NIH KL2 scholar. Her clinical focus is pediatric hematology, emphasizing bone marrow failure disorders, cancer predisposition syndromes, and thalassemia/dyserythropoietic anemias. Her research investigates epigenetic regulation of myeloid malignancies, clonal hematopoiesis in childhood cancer survivors, and molecular mechanisms underlying acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative disorders (MPD). Education: Bachelor's in Biochemistry (Indiana University), minor in Spanish Medical degree (Indiana University School of Medicine) Masters of Science in Clinical Sciences (UT Southwestern Center for Translational Medicine) Training: Pediatric residency with research pathway (Ohio State University/Nationwide Children’s Hospital) Pediatric hematology-oncology fellowship (UT Southwestern) Dr. Dickerson’s research bridges basic science and clinical practice, leveraging CRISPR-based epigenetic editing, genomic analysis, and translational studies to understand disease mechanisms. Key projects include interrogating enhancer dysregulation in leukemia, studying metabolic reprogramming in cancers, and evaluating clonal hematopoiesis in survivors of childhood cancers. Her work has advanced understanding of EZH2’s role in AML and identified therapeutic vulnerabilities in myeloid malignancies. Awards: 2015 Translational Research Scholar (UTSW Center for Translational Medicine) NIH KL2 Career Development Award Grants/Initiatives: NIH-funded investigator-initiated study on clonal hematopoiesis Industry/consortia-sponsored trials for bone marrow failure and rare blood disorders She collaborates with the Children’s Research Institute and North American Pediatric Aplastic Anemia Consortium, contributing to clinical trials and translational initiatives. Her lab focuses on developing biomarkers for disease severity (e.g., immature platelet fraction in pediatric COVID-19) and therapeutic strategies targeting epigenetic dependencies in leukemia.

Ramana Vinjamuriمشاهده پروفایل

دانشیار

• Brain-Machine Interfaces
• Neuroprosthetics and Exoskeletons
• Machine Learning
• +۴ مورد دیگر

Ramana Vinjamuri is an Associate Professor in the Department of Computer Science and Electrical Engineering at the University of Maryland, Baltimore County (UMBC). He holds a secondary appointment as Visiting Professor at the Indian Institute of Technology, Hyderabad, India. His academic journey includes a Ph.D. in Electrical Engineering from the University of Pittsburgh (2008), M.S. in Bioinstrumentation from Villanova University (2004), and B.Tech. in Electrical and Electronics Engineering from Kakatiya University (2002). Dr. Vinjamuri's research focuses on Brain-Machine Interfaces (BMIs) for upper-limb prostheses control , neuroprosthetics and exoskeletons , machine learning in motor control , and neurophysiological signal processing . His work extends synergy-based models to control 37-dimensional hand movements, addresses human-robot interaction through emotionally intelligent systems, and develops neurotechnologies for substance use disorder using wearable sensors and AI. NSF CAREER Award (2019) NSF IUCRC BRAIN Center Planning Grant (2020) Harvey N Davis Distinguished Teaching Assistant Professor Award (2018) His publications demonstrate expertise in EEG and EMG signal analysis , deep learning for motor decoding , synergy modeling , and humanoid robot control . The Vinjamuri Lab at UMBC involves graduate, undergraduate, and high school researchers, with international collaborations in India and the US.

Vicente Valeroمشاهده پروفایل

استاد

• Breast Cancer
• Medical Oncology
• Inflammatory Breast Cancer
• +۳ مورد دیگر

Dr. Vicente Valero is a Professor and Deputy Chairman in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center. He has been affiliated with MD Anderson since 1991, with expertise in breast cancer, particularly inflammatory breast cancer (IBC) and HER2-positive cancers. His academic credentials include an M.D. from Universidad Autonoma de Nuevo Leon, followed by postgraduate training in Internal Medicine at St. Elizabeth Hospital and Northeastern Ohio University College of Medicine, and fellowships in Hematology-Medical Oncology at the University of Cincinnati and The University of Texas Medical Branch in Galveston. Board-certified in Internal Medicine, Medical Oncology, and Hematology, Dr. Valero is a leading researcher in neoadjuvant therapies, molecular residual disease, and IBC treatment protocols. His research focuses on improving outcomes for metastatic breast cancer patients, optimizing surgical de-escalation strategies, and advancing immunotherapy and targeted therapies. He leads multiple clinical trials, including NRG-BR004 and NRG-BR003, and has authored over 150 peer-reviewed articles. Dr. Valero is recognized for his dedication to education, having received the Division of Medicine Teacher of the Year award twice and the Educator of the Month honor. He actively contributes to multidisciplinary quality assurance conferences and serves as a primary investigator for several funded research protocols. Key achievements include developing the R-IBC residual tumor burden calculator and pioneering studies on eliminating breast surgery for exceptional responders to systemic therapy. His work emphasizes translating research into clinical practice to enhance early detection, prevention, and treatment efficacy in breast cancer.

Sandrine Dudoitمشاهده پروفایل

استاد

• Statistical Methodology
• Computational Biology
• Genomics
• +۵ مورد دیگر

Sandrine Dudoit is a Professor and Chair of the Department of Statistics at the University of California, Berkeley. She earned her PhD in Statistics from UC Berkeley in 1999 and joined the faculty in 2001. Her research focuses on statistical methodology and computing with applications to genomics, biomedical research, and precision health. She co-founded the Bioconductor Project , an open-source software initiative for biological data analysis, and leads interdisciplinary projects in single-cell transcriptomics and computational biology. Education: PhD in Statistics (UC Berkeley, 1999), M.Sc. in Mathematics (Carleton University, Canada). Research interests include high-dimensional statistical learning, single-cell RNA-Seq analysis, stem cell differentiation in the olfactory system, and statistical computing. She collaborates with biologists like John Ngai to study neuroepithelial regeneration using cutting-edge sequencing technologies. Recent work emphasizes trajectory inference, biomarker discovery, and methodological advances in handling high-dimensional genomic data. Her lab develops tools for normalization, clustering, and differential expression analysis in large-scale biological datasets. She teaches courses on statistical genomics and serves as a leader in UC Berkeley’s Division of Computing, Data Science, and Society (CDSS). Advising: Supervises PhD students in statistical methodology, computational biology, and bioinformatics. Grants: Active in securing funding for interdisciplinary research projects in genomics and data science. Labs/Teams: Core member of the Center for Computational Biology (CCB) and contributes to the Bioconductor community.

Marla Kellerمشاهده پروفایل

استاد

• HIV Prevention in Women
• Vaginal Microbicides
• Pre-Exposure Prophylaxis (PrEP)
• +۴ مورد دیگر

Dr. Marla Keller is a tenured Professor of Medicine and Obstetrics & Gynecology at Albert Einstein College of Medicine, currently serving as Executive Dean and holder of the Jacob and Jeanne Barkey Chair in Medicine. Director, NIH-funded Harold and Muriel Block Institute for Clinical and Translational Research Interim Senior Associate Dean for Clinical and Translational Research Vice Chair of Research for Department of Medicine Dr. Keller's research focuses on: Biomedical HIV prevention strategies Vaginal microbicide development PrEP implementation in women Cervical cancer screening in HIV+ women Immune responses to SARS-CoV-2 COVID-19 clinical trials Her recent publications emphasize: HPV infection and cervical precancer Vaginal microbiome interactions PrEP delivery systems HIV/HSV coinfection dynamics Convalescent plasma therapy Metronidazole treatment response Key scientific awards include: Infectious Disease Mentoring Award (2013) COVID-19 Distinguished Service Award (2021) Spirit of Achievement Changemaker Award (2023) New York Super Doctor (2011-2015)

Audrey Gaskinsمشاهده پروفایل

دانشیار

• Maternal and Child Health
• Nutrition
• Obesity Prevention
• +۳ مورد دیگر

Audrey Gaskins is an Associate Professor in the Department of Epidemiology at Emory University's Rollins School of Public Health. Her research focuses on how environmental, dietary, and lifestyle factors influence reproductive health across the lifespan, with a primary emphasis on fertility and assisted reproductive technologies (ART). She holds a BSc in Engineering from Duke University and a Doctor of Science from Harvard T.H. Chan School of Public Health. Key areas of interest include maternal and child health, nutritional influences on fertility, air pollution effects on reproductive outcomes, and environmental epidemiology. She teaches courses such as Reproductive Epidemiology (EPI 746) and has affiliations with organizations like the American Society for Reproductive Medicine and the Society for Environmental Epidemiology. Her work frequently examines mechanisms linking exposures to reproductive health, leveraging ART patient cohorts to study biomarkers like antimüllerian hormone and phthalate metabolites. Notable studies include investigations into parental smoking's intergenerational effects on gestational diabetes and the role of air pollution in embryo development during IVF, as highlighted in media coverage. Dr. Gaskins' research also addresses dietary patterns (e.g., dairy, soy, and pesticide residues in produce) and their associations with semen quality and IVF success. She collaborates on projects like the EARTH Study, analyzing environmental exposures in fertility contexts.

Raquel Iniestaمشاهده پروفایل

استاد

• Machine Learning for Precision Medicine
• Ethics of AI
• Topological Data Analysis
• +۳ مورد دیگر

Raquel Iniesta is a Reader in Statistical Learning for Precision Medicine at King's College London, leading the Fair Modelling and TDA lab within the Department of Biostatistics & Health Informatics. Her expertise spans mathematics, statistics, and machine learning applied to precision medicine, with a focus on ethical AI integration in healthcare. She teaches advanced machine learning and statistical modeling courses and actively engages in scientific communication through workshops and media outreach. Her research emphasizes developing transparent AI models for personalized medicine, particularly in depression, hypertension, and neurodegenerative diseases. Notable contributions include studies on fasciculation analysis in ALS and ethical frameworks for healthcare AI. Publications highlight interdisciplinary approaches, combining machine learning with clinical and genetic data to improve predictive models. Dr. Iniesta leads educational initiatives, including the Machine Learning module and Introduction to Statistics programs, and contributes to public engagement by designing digital content and managing social media for research dissemination.

• Pediatric Otolaryngology
• Stem Cell Therapy
• Regenerative Medicine
• +۸ مورد دیگر

Christian J. Hochstim, MD, PhD, is a Clinical Assistant Professor of Otolaryngology at the University of Southern California. His clinical expertise includes complex airway disorders, pediatric tracheostomy management, and vocal cord paralysis. He completed a pediatric otolaryngology fellowship at Stanford University and earned his PhD in developmental biology at Caltech. His research focuses on regenerative medicine strategies for airway reconstruction and preventing stenosis, leveraging stem cell technology. Dr. Hochstim’s education includes a dual MD/PhD, with postdoctoral training in head and neck cancer at Stanford. His research bridges developmental biology and clinical otolaryngology, addressing challenges in airway reconstruction and pediatric surgical outcomes. His clinical interests span aerodigestive disorders, obstructive sleep apnea, and cochlear implantation. He has published extensively on pediatric tracheostomy quality of life, biofilm-associated stenosis, and disparities in healthcare access. Notable studies include repurposing evolutionary gill gene programs for outer ear development and evaluating opioid-free anesthesia in OSA surgery. Key contributions include analyzing prognostic factors in pediatric fungal rhinosinusitis and investigating respiratory risks in endoscopic procedures. His work emphasizes translational research with clinical impact, particularly in underserved pediatric populations.

• Rheumatology
• Liver Disease
• Alcoholic Hepatitis
• +۳ مورد دیگر

Krishnasai Abhishek Madathanapalli is a Clinical Fellow in the Section of Rheumatology, Allergy, and Immunology at Yale School of Medicine since July 2023. He holds the rank of Research Fellow and works under mentorship of Monique Hinchcliff, MD, MS. His academic journey spans diverse environments: born in Bahrain, medical training in India (MBBS 2018), residency at University of Connecticut (2023), and prior research experience at Indiana University’s Department of Gastroenterology and Hepatology. Education: MBBS in Medicine: Jawaharlal Institute of Post-Graduate Medical Education and Research, Pondicherry, India (2018) Residency in Internal Medicine: University of Connecticut School of Medicine (2023) Visiting Research Scholar: Indiana University Department of Gastroenterology and Hepatology Research Interests: Krishnasai’s work bridges rheumatology and immunology with liver disease research. He focuses on health-related quality of life assessment in chronic conditions, biomarker dynamics (e.g., myostatin), and translational studies for alcoholic hepatitis. His research emphasizes patient-centered outcomes and improving clinical tools for liver disease evaluation. Awards: Yale International Physician-Scientist Resident and Fellow Research Award (2023) Rheumatology Research Foundation Resident Research Preceptorship Award (2022, International) Advising & Grants: Supported by grants from the Rheumatology Research Foundation and Yale School of Medicine, he collaborates with the Clinical and Translational Research Accelerator directed by Dr. Hinchcliff. No formal advisees/students are listed, but his mentorship and grant activities reflect active participation in physician-scientist development programs. Labs & Teams: Affiliated with the Section of Rheumatology, Allergy, & Immunology at Yale and engaged in interdisciplinary research through the Janeway Society and Office of Physician-Scientist Development initiatives.

• Psychiatric Genetics
• Substance Use Disorders
• Gene-Environment Interaction
• +۵ مورد دیگر

Bao-Zhu Yang is a Researcher at Yale School of Medicine , specializing in the Department of Psychiatry . With a PhD from University at Albany (2001), his work focuses on genetic mechanisms underlying psychiatric disorders. Positions: Research Scientist in Psychiatry Labs: Gelernter Lab, Division of Human Genetics His research explores gene-environment interactions , admixture mapping , and comorbid substance use-depression using linkage/association methods. Supported by NIH K01 funding, he investigates genetic bases for conditions including childhood depression , alcoholism , and PTSD . Recent publications highlight: Microbiome studies in methamphetamine use disorder (2023-2025) Genetic polymorphism analyses in NGF and GABAergic pathways (2020-2024) Network approaches to nicotine-alcohol comorbidity (2019) Epigenetic research on child maltreatment effects (2020) Scientific Recognition: Young Investigator Award (2011) from NARSAD Brain and Behavior Research Foundation Active grant support includes NIH K01 career development award for gene-mapping in comorbid disorders. Collaborates with leading researchers including Joel Gelernter and Hongyu Zhao across 30+ joint publications. His work spans 15+ years with recent focus on integrative -omics approaches to addiction psychiatry. Based at 300 George St, New Haven, CT , Yang's laboratory work involves genetic epidemiology , transcriptomic integration , and neurogenetic mapping of substance use disorders.

Georg Langsمشاهده پروفایل

استاد

• Machine Learning
• Medical Imaging
• Precision Medicine
• +۳ مورد دیگر

Georg Langs is a Full Professor of Machine Learning in Medical Imaging at the Medical University of Vienna and Founding Director of the Computational Imaging Research Lab (CIR). He leads a 25-member interdisciplinary team focusing on machine learning methodologies for medical image analysis. Key roles include Director of the Joint Initiative on AI in Medical Imaging (European Institute of Biomedical Imaging Research) and Scientific Lead of the Respiratory Disease Phenotype Observatory (ZODIAC, UNO/IAEA). He is affiliated with MIT’s CSAIL and serves on advisory boards for global AI initiatives. Education: PhD in Computer Science, Graz University of Technology (2007) M.Sc. in Mathematics, Vienna University of Technology (2003) Research Interests: Machine learning-driven precision imaging, neuroimaging, clinical data phenotyping, and cross-species brain connectivity analysis. His work bridges imaging biomarkers with biological mechanisms and large-scale clinical data integration. Grants & Funding: Over €6M in competitive grants as Principal Investigator in the last two years. Projects include ARTEMIS (fatty liver disease digital twins) and AI-POD (personalized risk scores via imaging). Awards: 2022 IS3R Emerging Leaders Club 2022 National Academy of Medicine Emerging Leader Programme 2018 Advisor, AI Mission Austria 2030 Lab & Teams: CIR Lab focuses on AI-driven medical imaging solutions. Co-founded contextflow GmbH , a MedUni spin-off developing AI software for imaging analysis.

• Nanotechnology-based bioanalysis
• Mass spectrometry
• Lateral flow immunoassay
• +۵ مورد دیگر

Dr. Chang Lei is an ARC Discovery Early Career Researcher Award (DECRA) Fellow at the Department of Medical Sciences within the Faculty of Medicine and Health at The University of Sydney. She is also a member of The University of Sydney Nano Institute and the Charles Perkins Centre. With expertise in nanotechnology-based bioanalysis, mass spectrometry, lateral flow immunoassay, and tissue regeneration, Dr. Lei leads several innovative research projects focused on advancing healthcare through nanotechnology. Dr. Lei completed her PhD at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland (UQ). Her academic journey includes receiving the Queensland Government Advance Queensland Research Fellowship, the UQ Amplify Fellowship in 2021, and the prestigious ARC DECRA in 2024. Her research interests span across nanotechnology applications in healthcare, with particular focus on: Developing novel nanomaterials for single-cell metabolomics analysis Creating affordable and ultra-sensitive biomarker detection platforms Engineering silica bio-nanomaterials for stem cell differentiation and bone repair Advancing lateral flow immunoassay technologies using nanomaterials Applying nanotechnology to dental and craniofacial regeneration Dr. Lei's publication record demonstrates a strong focus on nanotechnology applications across multiple disciplines. Her recent work shows increasing emphasis on medical applications of nanomaterials, particularly in diagnostics, cancer therapy, and tissue regeneration. She has published in high-impact journals including Nature Science Review, Small, Biosensors and Bioelectronics, Angewandte Chemie, and Advanced Materials. Dr. Lei has received several notable awards and honors: 2024 ARC DECRA Fellow 2021 The University of Queensland Amplify Fellow 2020 GC Minimum Intervention Dentistry Research Award 2017 Advanced Queensland Research Fellow As a reviewer for scientific journals such as Science Advances, Journal of Nanobiotechnology, and Journal of Materials Chemistry B, and for ARC and NHMRC grants, Dr. Lei actively contributes to the scientific community. She also serves as an editor for Frontiers in Bioengineering and Biotechnology and Nano TransMed. Her current research projects are supported by grants including the ARC DECRA and the FMH Start-up Scheme. Dr. Lei is actively involved in several research groups and initiatives: Member of The University of Sydney Nano Institute Member of the Charles Perkins Centre Member of Australian and New Zealand Society for Mass Spectrometry Member of The Australian Materials Research Society Member of the Australian Nanotechnology Network